ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 137 filers reported holding ITEOS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 6.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $36,000 | +89.5% | 2,442 | +74.8% | 0.00% | – |
| Q1 2024 | $19,000 | -75.0% | 1,397 | -79.9% | 0.00% | – |
| Q4 2023 | $76,000 | +65.2% | 6,949 | +67.0% | 0.00% | – |
| Q3 2023 | $46,000 | +35.3% | 4,161 | +60.9% | 0.00% | – |
| Q2 2023 | $34,000 | +88.9% | 2,586 | +94.3% | 0.00% | – |
| Q1 2023 | $18,000 | -66.0% | 1,331 | -50.7% | 0.00% | – |
| Q4 2022 | $53,000 | +960.0% | 2,700 | +785.2% | 0.00% | – |
| Q3 2022 | $5,000 | +25.0% | 305 | +80.5% | 0.00% | – |
| Q2 2022 | $4,000 | -90.0% | 169 | -86.4% | 0.00% | – |
| Q1 2022 | $40,000 | -74.7% | 1,246 | -63.5% | 0.00% | – |
| Q4 2021 | $158,000 | +167.8% | 3,412 | +57.7% | 0.00% | – |
| Q3 2021 | $59,000 | -6.3% | 2,164 | -12.5% | 0.00% | – |
| Q2 2021 | $63,000 | +6.8% | 2,474 | +42.8% | 0.00% | – |
| Q1 2021 | $59,000 | +555.6% | 1,732 | +532.1% | 0.00% | – |
| Q4 2020 | $9,000 | – | 274 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $36,261,513 | 17.78% |
| Saturn V Capital Management LP | 636,158 | $8,422,732 | 4.67% |
| MPM BioImpact LLC | 1,745,943 | $23,116,285 | 4.66% |
| Boxer Capital, LLC | 2,154,058 | $28,520 | 1.32% |
| RA Capital Management | 4,417,259 | $58,484,509 | 1.10% |
| Octagon Capital Advisors LP | 596,000 | $7,891,040 | 1.10% |
| BVF INC/IL | 1,810,835 | $23,975,455 | 0.67% |
| 683 Capital Management, LLC | 585,000 | $7,745,400 | 0.56% |
| AlphaCentric Advisors LLC | 63,000 | $834,120 | 0.46% |
| DAFNA Capital Management LLC | 98,560 | $1,304,934 | 0.36% |